These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32772924)

  • 1. Advanced lipoprotein profile disturbances in type 1 diabetes mellitus: a focus on LDL particles.
    Amor AJ; Castelblanco E; Hernández M; Gimenez M; Granado-Casas M; Blanco J; Soldevila B; Esmatjes E; Conget I; Alonso N; Ortega E; Mauricio D
    Cardiovasc Diabetol; 2020 Aug; 19(1):126. PubMed ID: 32772924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk.
    Serés-Noriega T; Ortega E; Giménez M; Perea V; Boswell L; Mariaca K; Font C; Mesa A; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Nutr Metab Cardiovasc Dis; 2023 Jun; 33(6):1235-1244. PubMed ID: 37088651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.
    Gourgari E; Playford MP; Campia U; Dey AK; Cogen F; Gubb-Weiser S; Mete M; Desale S; Sampson M; Taylor A; Rother KI; Remaley AT; Mehta NN
    Cardiovasc Diabetol; 2018 Dec; 17(1):158. PubMed ID: 30567548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance lipoprotein abnormalities in newly-diagnosed type 2 diabetes and their association with preclinical carotid atherosclerosis.
    Amor AJ; Catalan M; Pérez A; Herreras Z; Pinyol M; Sala-Vila A; Cofán M; Gilabert R; Ros E; Ortega E
    Atherosclerosis; 2016 Apr; 247():161-9. PubMed ID: 26921744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
    Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Garvey WT; Lyons TJ;
    Atherosclerosis; 2016 Jan; 244():93-100. PubMed ID: 26600440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
    Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
    Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Switching From Statin Monotherapy to Ezetimibe/Simvastatin Combination Therapy Compared With Other Intensified Lipid-Lowering Strategies on Lipoprotein Subclasses in Diabetic Patients With Symptomatic Cardiovascular Disease.
    Le NA; Tomassini JE; Tershakovec AM; Neff DR; Wilson PW
    J Am Heart Assoc; 2015 Oct; 4(10):e001675. PubMed ID: 26486166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced lipoprotein profile in individuals with normal and impaired glucose metabolism.
    Puig-Jové C; Castelblanco E; Falguera M; Hernández M; Soldevila B; Julián MT; Teis A; Julve J; Barranco-Altirriba M; Franch-Nadal J; Puig-Domingo M; Ortega E; Amigó N; Alonso N; Mauricio D
    Rev Esp Cardiol (Engl Ed); 2022 Jan; 75(1):22-30. PubMed ID: 33785266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear magnetic resonance lipoproteins are associated with carotid atherosclerosis in type 1 diabetes and pre-eclampsia.
    Amor AJ; Vinagre I; Valverde M; Urquizu X; Meler E; López E; Quirós C; Giménez M; Codina L; Conget I; Barahona MJ; Perea V
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3362. PubMed ID: 32515046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.
    Gourgari E; Ma J; Playford MP; Mehta NN; Goldman R; Remaley AT; Gordon SM
    Cardiovasc Diabetol; 2019 Mar; 18(1):43. PubMed ID: 30922315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokines.
    Hughes TA; Calderon RM; Diaz S; Mendez AJ; Goldberg RB
    J Diabetes Complications; 2016; 30(4):657-68. PubMed ID: 26997169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.
    Colhoun HM; Otvos JD; Rubens MB; Taskinen MR; Underwood SR; Fuller JH
    Diabetes; 2002 Jun; 51(6):1949-56. PubMed ID: 12031985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk.
    Guardiola M; Plana N; Ibarretxe D; Cabré A; González M; Ribalta J; Masana L
    Clin Sci (Lond); 2015 Jun; 128(12):877-82. PubMed ID: 25649668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism.
    Lee JE; Min SH; Lee DH; Oh TJ; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Int J Cardiol; 2016 Dec; 225():327-331. PubMed ID: 27756036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Lefrandt JD
    Clin Biochem; 2014 Nov; 47(16-17):170-5. PubMed ID: 25149194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.